These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 35766180)

  • 1. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Jordà P; Bosman LP; Gasperetti A; Mazzanti A; Gourraud JB; Davies B; Frederiksen TC; Weidmann ZM; Di Marco A; Roberts JD; MacIntyre C; Seifer C; Delinière A; Alqarawi W; Kukavica D; Minois D; Trancuccio A; Arnaud M; Targetti M; Martino A; Oliviero G; Pipilas DC; Carbucicchio C; Compagnucci P; Dello Russo A; Olivotto I; Calò L; Lubitz SA; Cutler MJ; Chevalier P; Arbelo E; Priori SG; Healey JS; Calkins H; Casella M; Jensen HK; Tondo C; Tadros R; James CA; Krahn AD; Cadrin-Tourigny J
    Eur Heart J; 2022 Aug; 43(32):3041-3052. PubMed ID: 35766180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Eur Heart J; 2022 Aug; 43(32):e1-e9. PubMed ID: 35441664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Eur Heart J; 2019 Jun; 40(23):1850-1858. PubMed ID: 30915475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
    Carrick RT; De Marco C; Gasperetti A; Bosman LP; Gourraud JB; Trancuccio A; Mazzanti A; Murray B; Pendleton C; Tichnell C; Tandri H; Zeppenfeld K; Wilde AAM; Davies B; Seifer C; Roberts JD; Healey JS; MacIntyre C; Alqarawi W; Tadros R; Cutler MJ; Targetti M; Calò L; Vitali F; Bertini M; Compagnucci P; Casella M; Dello Russo A; Cappelletto C; De Luca A; Stolfo D; Duru F; Jensen HK; Svensson A; Dahlberg P; Hasselberg NE; Di Marco A; Jordà P; Arbelo E; Moreno Weidmann Z; Borowiec K; Delinière A; Biernacka EK; van Tintelen JP; Platonov PG; Olivotto I; Saguner AM; Haugaa KH; Cox M; Tondo C; Merlo M; Krahn AD; Te Riele ASJM; Wu KC; Calkins H; James CA; Cadrin-Tourigny J
    Eur Heart J; 2024 Feb; 45(7):538-548. PubMed ID: 38195003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy.
    Bosman LP; Nielsen Gerlach CL; Cadrin-Tourigny J; Orgeron G; Tichnell C; Murray B; Bourfiss M; van der Heijden JF; Yap SC; Zeppenfeld K; van den Berg MP; Wilde AAM; Asselbergs FW; Tandri H; Calkins H; van Tintelen JP; James CA; Te Riele ASJM
    Europace; 2022 Feb; 24(2):296-305. PubMed ID: 34468736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration.
    Cadrin-Tourigny J; Bosman LP; Wang W; Tadros R; Bhonsale A; Bourfiss M; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; Van der Heijden JF; Tandri H; Jongbloed JDH; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Circ Arrhythm Electrophysiol; 2021 Jan; 14(1):e008509. PubMed ID: 33296238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
    Agbaedeng TA; Roberts KA; Colley L; Noubiap JJ; Oxborough D
    Europace; 2022 Oct; 24(10):1665-1674. PubMed ID: 35298614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy.
    Gasperetti A; James CA; Carrick RT; Protonotarios A; Te Riele ASJM; Cadrin-Tourigny J; Compagnucci P; Duru F; van Tintelen P; Elliot PM; Calkins H
    Europace; 2023 Nov; 25(11):. PubMed ID: 37935403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation of a Risk Prediction Model for Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Baudinaud P; Laredo M; Badenco N; Rouanet S; Waintraub X; Duthoit G; Hidden-Lucet F; Redheuil A; Maupain C; Gandjbakhch E
    Can J Cardiol; 2021 Aug; 37(8):1263-1266. PubMed ID: 33675936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification for ventricular arrhythmias and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: an update.
    Cadrin-Tourigny J; Bosman LP; Tadros R; Talajic M; Rivard L; James CA; Khairy P
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):645-651. PubMed ID: 31422711
    [No Abstract]   [Full Text] [Related]  

  • 13. Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
    Gasperetti A; Carrick RT; Costa S; Compagnucci P; Bosman LP; Chivulescu M; Tichnell C; Murray B; Tandri H; Tadros R; Rivard L; van den Berg MP; Zeppenfeld K; Wilde AAM; Pompilio G; Carbucicchio C; Dello Russo A; Casella M; Svensson A; Brunckhorst CB; van Tintelen JP; Platonov PG; Haugaa KH; Duru F; Te Riele ASJM; Khairy P; Tondo C; Calkins H; James CA; Saguner AM; Cadrin-Tourigny J
    Circulation; 2022 Nov; 146(19):1434-1443. PubMed ID: 36205131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
    Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
    JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
    Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
    Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
    Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
    Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.
    Wang W; Cadrin-Tourigny J; Bhonsale A; Tichnell C; Murray B; Monfredi O; Chrispin J; Crosson J; Tandri H; James CA; Calkins H
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1396-1402. PubMed ID: 29894017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
    Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.
    Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD
    Europace; 2023 May; 25(5):. PubMed ID: 37213071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
    Molitor N; Hofer D; Çimen T; Gasperetti A; Akdis D; Costa S; Jenni R; Breitenstein A; Wolber T; Winnik S; Fokstuen S; Fu G; Medeiros-Domingo A; Ruschitzka F; Brunckhorst C; Duru F; Saguner AM
    Heart; 2023 Jul; 109(15):1146-1152. PubMed ID: 36889907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.